Skip to main content
Aytu BioPharma, Inc.SEC 8-K

Aytu BioPharma to Be Acquired by Rosemont Pharmaceuticals Holdings for $2.70 Per Share in Cash

What happened

Aytu BioPharma entered into a definitive merger agreement to be acquired by Rosemont Pharmaceuticals Holdings, Inc. via a tender offer for $2.70 per share in cash.

Source

Extracted by Autobound

From the Signal API record
Signal
SEC 8-K

What this signalsFilings often name leadership changes, deals and spending plans.

Form
8-K
Filed
Nov 16, 2026

More from Aytu BioPharma, Inc.

More SEC 8-K signals at other companies

The full record

From the Signal API record

Details

CIK
1385818
Accession number
0001437749-26-037155
Metric named
$2.70 per Share net in cash
Timeframe
Immediate
Filing year
2026
Why it matters
Integration needs coming
Signal category
Strategic
Event
acquisitionAnnounced

Topics and mentions

Events in the filing

  • Acquisition announced

Tags

  • acquisitionAnnounced

Extraction

Confidence
High
Relevance
95%
Sentiment
Positive
Detected
Nov 17, 2026
signal_type
sec-8k
signal_subtype
acquisitionAnnounced

Use this data

Get every SEC 8-K signal for Aytu BioPharma, Inc. and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Aytu BioPharma, Inc. this week?”

  2. Send it to your own tools

    The Signal API returns SEC 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/3d061e82-b664-4c53-b1bd-273bb52cf64e returns this record as JSON. POST /v1/companies/enrich returns every signal for aytubio.com.

{
  "signal_id": "3d061e82-b664-4c53-b1bd-273bb52cf64e",
  "signal_type": "sec-8k",
  "signal_subtype": "acquisitionAnnounced",
  "detected_at": "2026-11-17T07:03:14.626+00:00",
  "company": {
    "name": "Aytu BioPharma, Inc.",
    "domain": "aytubio.com"
  },
  "data": {
    "detail": "Aytu BioPharma entered into a definitive merger agreement to be acquired by Rosemont Pharmaceuticals Holdings, Inc. via a tender offer for $2.70 per share in cash. For sellers: Change-of-control transactions frequently trigger organizational restructuring and integration reviews of systems and vendor contracts.",
    "metrics": {
      "timeframe": "immediate",
      "dollar_context": "$2.70 per Share net in cash"
    },
    "summary": "Aytu BioPharma to Be Acquired by Rosemont Pharmaceuticals Holdings for $2.70 Per Share in Cash",
    "relevance": 0.95,
    "sentiment": "positive",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1385818/000143774926037155/aytu20261113_8k.htm",
    "filing_date": "2026-11-16",
    "filing_year": 2026,
    "sales_relevance": "Integration needs coming",
    "signal_category": "strategic"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.